Access to the KKR Investor Portal is provided to investors in Drawbridge Realty Partners, L.P. (the “Drawbridge Fund”) by Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”) solely in KKR’s capacity as an administrator to the Drawbridge Fund and at the direction of Drawbridge Realty (“Drawbridge”). Information regarding the Drawbridge Fund accessed through the KKR Investor Portal is confidential and intended for Drawbridge Fund investors only. The recipient should not distribute this Communication to any person (other than its legal, investment or tax advisors) without the prior consent of Drawbridge.
Drawbridge is an independently managed real estate investment vehicle. KKR has a financial and/or control interest in, and provides certain services to the Drawbridge Fund and/or its sponsor, but KKR is not the investment advisor to the Drawbridge Fund or any portfolio investment of the Drawbridge Fund. Further, KKR is under no obligation to provide the Drawbridge Fund with investment opportunities and in many cases will be prohibited from doing so by KKR’s internal policies and procedures. No person should rely upon the past performance or reputation of KKR or its investment products when considering any security offered by the Drawbridge Fund or Drawbridge.
五十嵐 啓朗(拠点:東京)2019年にKKRキャップストーン入社。KKRの投資先企業の事業強化と変革の支援に携わる。KKRキャップストーン入社以前は、バイエルにて執行役員として日本とアメリカにて7年間勤務。バイエルでは、日本にて眼科、オンコロジー、血液領域、婦人科、エスタブリッシュド製品等の事業部長を歴任、アメリカにおいてはVice Presidentとして血液腫瘍事業を立ち上げ、遺伝子標的癌部門の営業を管轄した。それ以前は、ボストンコンサルティンググループの東京オフィスにて、プロジェクトマネジャーとして経営/戦略コンサルティングに8年間従事。東京大学法学部にて学士号、スタンフォード大学経営大学院にてMBAを取得。